Company news

Avecho Biotechnology Limited news in 2026

Avecho Biotechnology Limited's news releases, calls and decks from 2026, newest first.

View company

September 2026 Quarterly Activities Report & Appendix 4C

October 27, 2026

September 2026 Quarterly Activities Report & Appendix 4C

October 27, 2026

Change of Chief Financial Officer

October 27, 2026

Response to ASX Price Query

October 21, 2026

Response to ASX Price Query

October 21, 2026

Avecho to present at the Canaccord Drug and Device Confe

October 12, 2026

Avecho to present at the ASX SMIDcaps Conference

September 22, 2026

Avecho enters final stage of Phase III insomnia trial

August 30, 2026

Appendix 4D and Half-year Financial Report

August 25, 2026

Avecho strengthens BD capability with senior appointment

August 23, 2026

Small Holding Share Sale Facility Completion

August 11, 2026

Japanese patent granted for CBD capsule

August 2, 2026

June 2026 Quarterly Activities Report & Appendix 4C

July 28, 2026

Positive interim analysis advances Avecho Phase III insomnia program

June 29, 2026

Positive interim results from Phase III insomnia program

June 23, 2026

Receipt of Research & Development Tax Incentive

May 21, 2026

Avecho completes treatment for Phase III interim analysis

May 20, 2026

Expiry of Listed Options

May 12, 2026

March 2026 Quarterly Activities Report & Appendix 4C

April 28, 2026

Avecho completes recruitment for Phase III interim analysis

March 1, 2026

Annual Report 31 December 2025

February 27, 2026

December 2025 Quarterly Activities Report & Appendix 4C

January 29, 2026

Decks in 2026